Innovation

This category can have multiple entries per HIN per time point.

Innovation Name

Table Identifier?	Yes
Description	The name of the innovation that you are supporting
Data Format	Text, up to 255 characters
Response standards	Do not exceed 255 characters
Reported to	IRLSS

Innovation Type

Table Identifier?	No
Description	The type of innovation
Data Format	Dropdown
Response standards	Select all that apply. If Other is selected, must provide text description and must not exceed 255 characters.
Dropdown Options	Medical device In vitro diagnostic Pharmaceutical Digital (including apps, platforms, software) Diagnostics Artificial intelligence (AI) Education or training of workforce Personal protective equipment (PPE) Models of care and clinical pathways Estates and facilities Travel and transport Food and nutrition Data and monitoring Service Therapeutics Unknown Other (please specify)
Reported to	IRLSS

Care Setting

Table Identifier?	No
Description	The care setting where the innovation is intended to be deployed
Data Format	Dropdown
Response standards	Select up to 3 options that apply. If Other is selected, must provide text description and must not exceed 255 characters.
Dropdown Options	Academia Acute Trust - Inpatient Acute Trust - Outpatient Ambulance Care Homes or Care setting Community Service Day Patient Dentistry End-of-life care (EOLC) ICS Industry Local Authority - Education Mental Health Trust Mental Health Community Services Optometry Person's home Pharmacies GP Primary Care Social Care Third Sector Organisations Urgent & Emergency Unknown Other (please specify)
Reported to	IRLSS

Clinical Areas

Table Identifier?	No
Description	The clinical areas that the innovation supports
Data Format	Dropdown
Response standards	Select all that apply. If Other is selected, must provide text description and must not exceed 255 characters.
Dropdown Options	Non-clinical area Ageing Antimicrobial Stewardship Blood and immune system conditions Cancer Cardiovascular conditions Chronic and neuropathic pain Chronic fatigue syndrome CVD: AF/Stroke CVD: CKD CVD: Diabetes CVD: Heart Failure CVD: Lipids CVD: Obesity CVD: Hypertension Cystic fibrosis Diabetes and other endocrinal, nutritional and metabolic conditions Digestive tract conditions Disease Agnostic Ear, nose and throat conditions Eye conditions Fertility, pregnancy and childbirth Genomic Medicine Gynaecological conditions Immunology Infections Injuries, accidents and wounds Kidney conditions Liver conditions Mental health and behavioural conditions Mental Health: ADHD Mental Health: Autism Mental Health: Dementia Multiple long-term conditions Musculoskeletal conditions Neurological conditions Oral and dental health Respiratory: Other conditions Respiratory: Asthma Respiratory: COPD Respiratory: Infection Respiratory: Sleep and sleep conditions Sepsis Skin conditions Urological conditions Women's Health Wound Management Nutritional products Pharmacy Primary Care Radiology or Imaging Surgery Unknown Other (please specify)
Reported to	IRLSS

Anticipated Benefit

Table Identifier?	Yes
Description	The benefit that the innovation is expected to deliver. Improved patient outcomes and safety - this includes improved quality of care, patient safety improvements, patient access Operational efficiency - this includes workflow optimisation, reduced waiting times, resource utilisation Financial and cost efficiency - this includes cost savings, revenue generation, reduced hospital readmissions Staff well-being and retention - this includes workforce development, job satisfaction and retention, staff productivity) Regulatory compliance and risk management - this includes data security and privacy, risk reduction Environmental impact
Data Format	Dropdown
Response standards	Choose one per benefit added
Dropdown Options	Improved patient outcomes and safety Operational efficiency Financial and cost efficiency Staff well-being and retention Regulatory compliance and risk management Environmental impact
Reported to	IRLSS

Anticipated Benefit Timeline

Table Identifier?	No
Description	The approximate time period for the benefit to be delivered from when the innovation is implemented, based on evidence or manufacturer claim. This refers to when an organisation can expect to see benefits if they adopted this innovation, not the project timeline.
Data Format	Dropdown
Response standards	Choose one option
Dropdown Options	1 - 6 months 6 months - 1 year 1 - 3 years 3 - 5 years 5 - 10 years
Reported to	IRLSS

Standards and Certifications

Table Identifier?	No
Description	Which standards and certifications does the product already have?
Data Format	Dropdown
Response standards	Select all that apply. If Other is selected, must provide text description and must not exceed 255 characters.
Dropdown Options	UKCA/CE Class I medical device UKCA/CE Class IIa medical device UKCA/CE Class IIb medical device UKCA/CE Class III medical device In-vitro diagnostics general In-vitro diagnostics self-test In-vitro diagnostics Annex II List B In-vitro diagnostics Annex II List A Marketing authorisation CQC registration Digital Technology Assessment Criteria (DTAC) Pending Unknown Other (please specify)
Reported to	IRLSS

User Design and Testing

Table Identifier?	No
Description	Which groups of end users were involved in designing, developing, or testing the innovation?
Data Format	Dropdown
Response standards	Select all that apply. If not applicable, please select Not applicable.
Dropdown Options	Not applicable Clinical or social care professionals working in the UK health and social care system Clinical or social care professionals working outside the UK Non-clinical healthcare staff Patients Service users Carers
Reported to	IRLSS

Case Study

Table Identifier?	No
Description	Is there a case study for this innovation?
Data Format	Yes/No values
Response standards	Choose one option
Reported to	IRLSS

Readiness Level

Table Identifier?	No
Description	What is the current Readiness Level of the Innovation, using the Technology Readiness Level framework (1-9)?
Data Format	Dropdown
Response standards	Select all that apply. If not applicable, please select Not applicable.
Dropdown Options	Not applicable Idea is formulated Idea is explicitly described Experimental proof of concept Elements of innovation validated in controlled environment (prototype) Whole innovation validated in controlled environment Whole innovation validated in real world environment Whole innovation evaluated in real world environment Whole innovation demonstrated in real world environment Whole innovation proven functional in multiple real world settings Unknown
Reported to	Network

Organisation Name

Table Identifier?	No
Description	Does this innovation link with an organisation? If so, please select the relevant Organisation Name from the dropdown. Otherwise, please select "Not applicable".
Data Format	Dropdown
Response standards	Choose one option
Dropdown Options	From Organisation Name
Reported to	IRLSS